This study investigates advanced solid tumors. It assesses the safety and how the body processes the investigational medication.
The purpose of this study is to evaluate the safety, tolerability, and early effects of the investigational medication in individuals with advanced solid tumors.
- Who can participate: Adults with advanced solid tumors, including metastatic melanoma, advanced breast cancer, advanced non-small cell lung cancer, and advanced pancreatic adenocarcinoma, may qualify. Participants must have progressed after standard therapy or have no available standard therapy options.
- Study details: Participants will receive an investigational medication.